Skip to content

Success of Paravertebral Blocks in Analgesia for Interventional Hepatic Procedures

Randomised Double Blind Controlled Study of the Effectiveness of Paravertebral Nerve Block in Decreasing Analgesia Requirements and Improving Patient Experience During Interventional Hepatic Procedures.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01711450
Enrollment
0
Registered
2012-10-22
Start date
2012-12-31
Completion date
2013-06-30
Last updated
2016-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Neoplasms

Brief summary

This study is aimed at assessing whether performing a paravertebral block (a type of regional pain relief) can reduce the pain and anxiety patients experience during radiological procedures on the liver.

Detailed description

Percutaneous procedures of the liver can be very painful and range from bliliary drain insertions to tumor ablation procedures. The study will randomize patients in two groups, one receiving a paravertebral nerve block prior to the procedure and one receiving a sham procedure in which saline will be injected in the paravertebral space. Pain scores and use of IV sedation will be monitored post procedure and both groups will be compared to assess whether paravetebral nerve blocks are effective at reducing pain in patients receiving such procedures.

Interventions

PROCEDUREParavertebral block

Injection of local anaesthesia into paravertebral space to provide analgesia

PROCEDUREControl sham procedure

Injection of Normal saline into the paravertebral space

Sponsors

Richard Lindsay
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Male or non-pregnant female subjects, between the ages of 18 and 80 at the time of enrollment. Subjects referred for liver/biliary interventions to the angiography department. Written informed consent to participate in the study. Ability to comply with the requirements of the study procedures

Exclusion criteria

* Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment. Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study. Patients will only be excluded on this basis following discussion with another interventional radiologist. Subjects who are uncooperative or cannot follow instructions. Mental state that may preclude completion of the study procedure or ability to obtain informed consent. Pregnant or nursing female subjects. Patient who are to undergo liver biopsy or routine biliary tube exchange. Patients with neurological/spinal conditions, or a BMI over 40, that would prevent safe/effective or well-targeted paravertebral blockade. Patient unable to tolerate the paravertebral block procedure, for example due to inability to lie prone

Design outcomes

Primary

MeasureTime frame
Dose of intravenous sedation required during and after the procedure1 hour

Secondary

MeasureTime frame
Improvement in analogue pain scoring after the procedure1 hour
Procedure duration1 hour
Complication rate of liver procedure24 hours
Complication rate of paravertebral block1 hour

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026